OverviewSuggest Edit
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. It offers a diverse portfolio of cell-based product candidates with three programs in Phase 3 clinical studies. The Company's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, orthopedic spine conditions, and cardiovascular disorders.
| Type | Public | |
| Founded | 2004 | |
| HQ | Melbourne, AU | Map |
| Website | mesoblast.com | |
| Employee Ratings | More |
Recent NewsAll News
- Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease
- Thinking about buying stock in Canoo, Cidara Therapeutics, Ford Motor, Mesoblast, or Reliance Global?
- Mesoblast and Oaktree Capital Enter Into Refinancing and Expansion of Senior Debt Facility
- Mesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease Conference
Key People/Management at Mesoblast
Silviu Itescu
Joseph R. Swedish
Josh Muntner
Shawn Cline Tomasello
Peter Howard
Fred Grossman
Mesoblast Office Locations
Mesoblast Financials and Metrics
Mesoblast Revenue
Market capitalization (1-Oct-2021) | 1.1b |
Closing stock price (1-Oct-2021) | 1.6 |
Mesoblast Cybersecurity Score
Mesoblast Environment, Social & Governance (ESG) Ratings
Mesoblast Online and Social Media Presence
3.97k Twitter followers
Mesoblast has 3.97k Twitter Followers. The number of followers has increased 0.8% quarter over quarter
Mesoblast's Trends
Twitter Engagement Stats for @Mesoblast
343
Tweets
234
Following
4k
Followers
2
Tweets last 30 days
27
Avg. likes per Tweet
100%
Tweets with engagement
Mesoblast News and Updates
Thinking about buying stock in Canoo, Cidara Therapeutics, Ford Motor, Mesoblast, or Reliance Global?
Mesoblast and Oaktree Capital Enter Into Refinancing and Expansion of Senior Debt Facility
Mesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease Conference
Mesoblast Provides Update on Program for Chronic Low Back Pain Due to Degenerative Disc Disease
Mesoblast Operational Highlights and Upcoming Milestones
Mesoblast Frequently Asked Questions
When was Mesoblast founded?
Mesoblast was founded in 2004.
Who are Mesoblast key executives?
Mesoblast's key executives are Silviu Itescu, Joseph R. Swedish and Josh Muntner.
How many employees does Mesoblast have?
Mesoblast has 102 employees.
Who are Mesoblast competitors?
Competitors of Mesoblast include Celltex, AXON Neuroscience and Human Stem Cells Institute.
Where is Mesoblast headquarters?
Mesoblast headquarters is located at Level 38/55 Collins St, Melbourne.
Where are Mesoblast offices?
Mesoblast has offices in Melbourne, New York and Singapore.
How many offices does Mesoblast have?
Mesoblast has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies